What are the latest trends in drug supply to Europe? What drugs are causing the most harm and concern today? What are the most recent developments in drug prevention, treatment and policy? These and other questions are explored by the EU drugs agency (EMCDDA) in its annual overview of the European drug situation.

This annual overview of the European drug situation provides a comprehensive analysis of the latest tendencies across 30 countries (28 EU, Turkey and Norway). In print and pdf in 24 languages, the report examines: drug supply and the market; drug use prevalence and trends; and drug-related health problems and responses to them.